These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Successful use of rituximab in fibrillary glomerulopathy.
    Author: Chaudhary A, Gyamlani G, Cossey NL, Walker PD, Wall BM.
    Journal: Ren Fail; 2014 Aug; 36(7):1151-4. PubMed ID: 24831880.
    Abstract:
    Fibrillary glomerulopathy (FG) can occur either alone or co-existing with other proteinuric glomerular disorders. FG has been associated with poor renal outcomes leading to End Stage Renal Disease (ESRD). Since FG is a relatively rare disorder, limited information is available concerning treatment protocols. We present two patients with FG who were treated with rituximab after they had already progressed to stage 3 chronic kidney disease (CKD) with worsening proteinuria. Rituximab therapy resulted in long-term stabilization of renal function.
    [Abstract] [Full Text] [Related] [New Search]